Update of adjuvant therapy for malignant melanoma and carcinoma of the breast: whom do you believe?
作者信息
Humphrey L J
出版信息
Am Surg. 1980 Jan;46(1):20-3.
PMID:7362145
Abstract
摘要
相似文献
1
Update of adjuvant therapy for malignant melanoma and carcinoma of the breast: whom do you believe?
Am Surg. 1980 Jan;46(1):20-3.
2
Breast cancer. Part 2: Management.
Prof Nurse. 1998 Aug;13(11):791-5; quiz 790.
3
Immediate reconstruction after neoadjuvant chemotherapy: effect on adjuvant treatment starting and survival.新辅助化疗后立即重建：对辅助治疗开始及生存的影响
Ann Surg Oncol. 2005 Feb;12(2):161-6. doi: 10.1245/ASO.2005.04.003. Epub 2005 Feb 4.
4
Decision making in surgery: management of symptomatic early breast carcinoma.
Br J Hosp Med. 1994;51(6):287-9.
5
Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast.乳腺上皮癌肉瘤样化生的生物学差异及治疗意义
J Am Coll Surg. 1995 Feb;180(2):193-9.
6
[1st revision of the National Consensus on Breast Cancer Treatment].[《乳腺癌治疗国家共识》第一次修订版]
Ginecol Obstet Mex. 2002 Jul;70:349-60.
7
Breast cancer therapy and treatment guidelines.乳腺癌治疗与治疗指南。
Nurse Pract. 2006 Oct;31(10):59-63.
8
[Therapeutic update on cancer of the breast].
Bull Cancer. 2000 Jan;87(1):49-62.
9
The multidisciplinary approach a need in optimal management of breast cancer.多学科方法是乳腺癌最佳管理所必需的。
Arch Geschwulstforsch. 1980;50(6):563-8.
10
Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.局部晚期乳腺癌治疗的进展：多学科治疗方法
Eur Rev Med Pharmacol Sci. 2007 Sep-Oct;11(5):283-9.
引用本文的文献
1
Adjuvant chemotherapy of breast cancer: hope--reality--hazard?乳腺癌辅助化疗：希望——现实——风险？
Klin Wochenschr. 1984 Feb 15;62(4):149-61. doi: 10.1007/BF01731637.
Zotero 插件